1don MSN
Analysis - AI spending, strong corporate profits, Fed rate cuts seen as key to 2026 stock market
The U.S. stock market is closing the books on a third straight year of double-digit percentage gains. A fourth stellar year ...
24/7 Wall St. on MSN
Stock market disconnect: High-flying S&P 500 run vs. Fed’s dire warning on tariff-driven unemployment
Quick Read The S&P 500 is up 16% this year but trades at over 23 times forward earnings. A Federal Reserve study found tariffs will likely raise unemployment and slow GDP growth in the near term. An ...
Discover the Center for Research in Security Prices (CRSP) at the Booth School of Business, including its historical data on ...
NEW YORK, NEW YORK - JULY 29: Baiju Bhatt (right) and Vlad Tenev, founders of the online brokerage Robinhood, walk along Wall Street after going public with an IPO earlier in the day on July 29, 2021 ...
A new academic study said people are diverting stock investments into legal gambling. The researchers founded that household investments are reduced by roughly $2 for ever dollar wagered. This has had ...
Nike stock experienced a significant rise in value over four decades, leading to a challenging sell recommendation despite investor sentiment. Despite initial resistance, subsequent sell calls on Nike ...
The high stakes of message delivery and misinformation are not new phenomena. Hessian Colonel Johann Rall was too busy to read an intel note from a British sympathizer during a Christmas party in 1776 ...
Shares of semiconductor equipment maker Lam Research (NASDAQ:LRCX) jumped 1.6% in the morning session after Morgan Stanley raised its price target on the stock to $158 from $137. The firm kept its ...
Lam Research (NASDAQ:LRCX) stock has seen a significant surge this year, climbing 22% and far outpacing the S&P 500’s modest 2% gain. This impressive performance is largely due to the company’s robust ...
Spero Therapeutics (NASDAQ:SPRO) stock tumbled 20% post-market after the company announced it was cutting its workforce by 39% in the wake of a failed Phase 2 study for its drug SPR720. In a statement ...
GRI Bio, Inc.’s GRI shares plummeted 36.9% on April 1 after the company announced the pricing of a public offering of stock of $5 million. Earlier in the day, the stock surged after the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results